Literature DB >> 21402119

Mechanisms of antidepressant action: an integrated dopaminergic perspective.

S Porcelli1, A Drago, C Fabbri, A Serretti.   

Abstract

The molecular mechanisms that cause and maintain the major depressive disorder (MDD) are currently unknown. Consistently, antidepressant treatments are characterized by insufficient success rates. This causes high social costs and severe personal sufferings. In the present review we analyze some of the paradigms that are used to explain MDD, particularly from the perspective of the dopaminergic (DA) system. DA has been more classically associated with psychosis and substance abuse disorders, even though a role of DA in MDD has been proposed as well and some antidepressants with DA profile exist. In the present work, we review some of the molecular mechanisms that underpin MDD from the perspective of the dopaminergic system, in the hope of unifying some of the major theories of MDD - the monoaminergic, inflammatory, epigenetics, neurotrophin and anti-apoptotic theories. Several shared components of these theories are highlighted, partially accounted by the functions of the DA system (see supplementary video).
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21402119     DOI: 10.1016/j.pnpbp.2011.03.005

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  7 in total

Review 1.  Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance.

Authors:  Melissa L Perreault; Ahmed Hasbi; Brian F O'Dowd; Susan R George
Journal:  Neuropsychopharmacology       Date:  2013-06-18       Impact factor: 7.853

2.  Amygdala-ventral pallidum pathway decreases dopamine activity after chronic mild stress in rats.

Authors:  Chun-Hui Chang; Anthony A Grace
Journal:  Biol Psychiatry       Date:  2013-09-28       Impact factor: 13.382

3.  Risky decision-making and ventral striatal dopamine responses to amphetamine: a positron emission tomography [(11)C]raclopride study in healthy adults.

Authors:  Lynn M Oswald; Gary S Wand; Dean F Wong; Clayton H Brown; Hiroto Kuwabara; James R Brašić
Journal:  Neuroimage       Date:  2015-03-18       Impact factor: 6.556

Review 4.  From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment.

Authors:  Chiara Fabbri; Stefano Porcelli; Alessandro Serretti
Journal:  Can J Psychiatry       Date:  2014-02       Impact factor: 4.356

5.  Withdrawal of caffeine after its chronic administration modifies the antidepressant-like activity of atypical antidepressants in mice. Changes in cortical expression of Comt, Slc6a15 and Adora1 genes.

Authors:  Aleksandra Szopa; Ewa Poleszak; Urszula Doboszewska; Mariola Herbet; Katarzyna Świąder; Elżbieta Wyska; Anna Serefko; Aleksandra Wlaź; Agnieszka Korga; Marta Ostrowska; Piotr Juś; Szymon Jedynak; Jarosław Dudka; Piotr Wlaź
Journal:  Psychopharmacology (Berl)       Date:  2018-06-07       Impact factor: 4.530

6.  Treatment resistant adolescent depression with upper airway resistance syndrome treated with rapid palatal expansion: a case report.

Authors:  Paul Miller; Mala Iyer; Avram R Gold
Journal:  J Med Case Rep       Date:  2012-12-04

Review 7.  Use of antipsychotics in the treatment of depressive disorders.

Authors:  Ping Wang; Tianmei Si
Journal:  Shanghai Arch Psychiatry       Date:  2013-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.